Neurology Central

Multiple sclerosis: new UK guidelines on disease-modifying therapies

The UK National Institute for Health and Care Excellence (NICE) has issued its Final Appraisal Determination recommending the use of four out of six disease-modifying therapies (DMTs) in relapsing–remitting multiple sclerosis (RRMS).
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.